4 June 2021 - Innovative Medicines Canada calls on the federal government to suspend the implementation of the Patented Medicines ...
18 May 2021 - Large increase likely after end of Brexit grace period, warns UUP head Simon Aiken. ...
23 April 2021 - The latest dustup over the cost of cystic fibrosis medicines sold by Vertex Pharmaceuticals is taking ...
20 April 2021 - We agree that there is always likely to be some tension between commercial interests and maximising societal ...
22 April 2021 - When Bluebird Bio secured European approval for its gene therapy to treat beta thalassaemia in 2019, ...
21 April 2021 - The sale of Piqray (alpelisib) will be discontinued by Novartis in accordance with Section 4 (7) ...
13 April 2021 - For countries in Europe, negotiating a deal with a pharma company over drug prices is the ...
21 January 2021 - A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug spending ...
21 January 2021 - In 2019, the Canadian Drug Insurance Pooling Corporation's (CDIPC) high-cost drug sharing framework provided coverage to ...
20 January 2021 - Indicative 1 April 2021 prices resulting from the 2021 April Cycle of Price Disclosure have now been ...
8 January 2021 - Changes meant to bring down price of prescription drugs pushed to 1 July 2021. ...
21 December 2020 - The summary of price disclosure price reductions for the 2021 April Cycle has now been published. ...
16 November 2020 - The pharmaceutical industry has made a last-ditch C$1 billion ($761 million) proposal to the Canadian government ...
9 November 2020 - The NHS could improve patients’ access to new cancer treatments by paying different prices for drugs ...
30 October 2020 - A fascinating insight from the first round of Public Summary Documents from the July 2020 PBAC ...